When should pharmacologic therapies be reevaluated in patients with acute urticaria?

Updated: Mar 21, 2018
  • Author: Henry K Wong, MD, PhD; Chief Editor: Michael A Kaliner, MD  more...
  • Print

As advised in the 2013 EAACI/GA2LEN/EDF/WAO management guideline, due to the fluctuating nature of acute urticaria and the chance that spontaneous remission can occur at any time, continued or alternative drug treatment should be reevaluated every 3-6 months. [76, 48, 49]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!